PuSH - Publikationsserver des Helmholtz Zentrums München

41 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Huber, M.B. et al.: Long-term weight gain in obese COPD patients participating in a disease management program: A risk factor for reduced health-related quality of life. Respir. Res. 22:226 (2021)
2.
Kellerer, C.* et al.: Prediction of lung emphysema in COPD by spirometry and clinical symptoms: Results from COSYCONET. Respir. Res. 22:242 (2021)
3.
Maqhuzu, P.N. et al.: Cost drivers in the pharmacological treatment of interstitial lung disease. Respir. Res. 22:218 (2021)
4.
Huber, M.B. et al.: The relationship between body mass index and health-related quality of life in COPD: Real-world evidence based on claims and survey data. Respir. Res. 21:291 (2020)
5.
Kahnert, K.* et al.: The impact of COPD on polyneuropathy: Results from the German COPD cohort COSYCONET. Respir. Res. 21:28 (2020)
6.
Veit, T. et al.: Variability of forced vital capacity in progressive interstitial lung disease: A prospective observational study. Respir. Res. 21:270 (2020)
7.
Wälscher, J.* ; Witt, S. ; Schwarzkopf, L. & Kreuter, M.*: Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment - a German claims data analysis. Respir. Res. 21:73 (2020)
8.
Flexeder, C. et al.: Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey. Respir. Res. 20:33 (2019)
9.
Kirsch, F. et al.: Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: Results from the LQ-DMP study. Respir. Res. 20:215 (2019)
10.
von Siemens, S.M.* et al.: Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: Results from the COSYCONET cohort study. Respir. Res. 20:30 (2019)
11.
von Siemens, S.M.* et al.: The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: Results from the COSYCONET cohort. Respir. Res. 20:257 (2019)
12.
Witt, S. et al.: Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis. Respir. Res. 20:47 (2019)
13.
Knüppel, L. et al.: FK506-binding protein 10 (FKBP10) regulates lung fibroblast migration via collagen VI synthesis. Respir. Res. 19:67 (2018)
14.
Lehmann, M. et al.: Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Respir. Res. 19:175 (2018)
15.
Schwarzkopf, L. ; Witt, S. ; Waelscher, J.* ; Polke, M.* & Kreuter, M.*: Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis. Respir. Res. 19:73 (2018)
16.
Szentes, B.L. et al.: Quality of life assessment in interstitial lung diseases: A comparison of the disease-specific K-BILD with the generic EQ-5D-5L. Respir. Res. 19:101 (2018)
17.
George, L.* et al.: Transcriptomic analysis comparing mouse strains with extreme total lung capacities identifies novel candidate genes for pulmonary function. Respir. Res. 18:152 (2017)
18.
Kahnert, K.* et al.: Transfer factor for carbon monoxide in patients with COPD and diabetes: Results from the German COSYCONET cohort. Respir. Res. 18:14 (2017)
19.
Karl, F. et al.: Costs and health-related quality of life in Alpha-1-antitrypsin deficient COPD patients. Respir. Res. 18:60 (2017)
20.
Luzak, A. et al.: Which early life events or current environmental and lifestyle factors influence lung function in adolescents? - Results from the GINIplus & LISAplus studies. Respir. Res. 18:138 (2017)